Rocket Pharmaceuticals
RCKT
RCKT
87 hedge funds and large institutions have $622M invested in Rocket Pharmaceuticals in 2018 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 34 increasing their positions, 13 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
4% more funds holding
Funds holding: 84 → 87 (+3)
2.17% more ownership
Funds ownership: 92.77% → 94.94% (+2.2%)
31% less capital invested
Capital invested by funds: $906M → $622M (-$284M)
Holders
87
Holding in Top 10
4
Calls
$194K
Puts
$169K
Top Buyers
| 1 | +$15.7M | |
| 2 | +$11.2M | |
| 3 | +$6.97M | |
| 4 |
EC
EcoR1 Capital
San Francisco,
California
|
+$6.67M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$6.66M |
Top Sellers
| 1 | -$19.1M | |
| 2 | -$2.45M | |
| 3 | -$2.37M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$2.08M |
| 5 |
AA
ALPS Advisors
Denver,
Colorado
|
-$1.73M |